Specialized Medical Company
TTADAWUL:401912.27
SAR
-0.51
(-3.99%)
ISIN
SA16B0CHUPH2
Return %
Stock
S&P 500
1Y
-32.77
14.20
3Y
- -
81.12
5Y
- -
68.34
Capital Structure
SAR
•
in mil. unless spec.Working Capital
SAR
•
in mil. unless spec.Growth Rates
SAR
•
in mil. unless spec.Quarterly Revenue
SAR
•
in mil. unless spec.Quarterly Earnings Per Share
SAR
•
in mil. unless spec.Quarterly Dividends Per Share
SAR
•
in mil. unless spec.Company Description
- CEO
- Bassam Tayseer Chahine
- Full Time Employees
- 3,353
- Sector
- Health services
- Industry
- Hospital/Nursing management
- Address
- Building 6678 King Fahad Road Riyadh RY Saudi Arabia 12311-4405
- IPO Date
- Jun 25, 2025
- Website
- smc.com.sa
- Similar Companies
- Business
- Specialized Medical Company (SMC), listed on the Saudi Exchange under ticker 4019.SR and headquartered in Riyadh, Saudi Arabia, is a leading manufacturer and distributor of medical and surgical products serving the healthcare sector across the Kingdom and the wider Middle East region. Established in 1988, the company offers a comprehensive portfolio of core products and services including disposable medical supplies such as syringes, needles, IV cannulas, and blood collection tubes under its own brands like SMC and Mediplus; surgical instruments and sterilization products; diagnostic equipment and laboratory consumables; wound care solutions; and healthcare logistics and distribution services through its subsidiary network. SMC operates primarily in Saudi Arabia with distribution hubs in major cities like Jeddah and Dammam, extending its reach to Gulf Cooperation Council countries and select international markets via strategic partnerships. In recent developments, the company expanded its manufacturing capacity in 2025 through a new facility in Riyadh for high-volume disposable production, announced a SAR 150 million funding round in late 2024 backed by local investors to support product innovation and export growth, and formed a strategic alliance with a leading European medical device supplier in early 2026 to introduce advanced imaging diagnostics tailored for regional hospitals. These initiatives reflect SMC's ongoing shift toward self-sufficiency in critical medical supplies amid Saudi Vision 2030 healthcare localization goals, alongside the launch of its digital supply chain platform for hospital procurement efficiency. The company targets public and private hospitals, clinics, pharmacies, and government health authorities as primary customers, maintaining a focus on regulatory compliance with SFDA standards and international quality certifications.